PIPE Firm funded. Going to 0.$QBIO was funded by a firm specializing in PIPE transactions with small and micro cap companies. The firms members have previously been investigated by the SEC. Check out QBIO on whalewisdom to begin your DD.
−2.05 MUSD
284.35 KUSD
139.98 M
About Q BioMed Inc.
Sector
CEO
Denis D. Corin
Headquarters
New York
Website
Employees (FY)
7
Founded
2013
FIGI
BBG0063BQSW3
Q BioMed, Inc. operates as a biomedical acceleration and development company. It focuses on acquiring and in-licensing pre-clinical, clinical-stage and approved life sciences therapeutic products. Its products include Strontium-89, MetastronTM, QBM-001, Uttroside-B, and MAN 01. The company was founded by Enrique Navas on November 22, 2013 and is headquartered in New York, NY.
$QBIO Bull Flag Pattern with Explosive Upside PotentialQBIO has a float of just 18.6 million shares. The stock is trading on a stick of dynamite.
We have seen this explosive character several times in the past few months. This stock can take off like a rocket. On three separate occasions, we have seen QBIO shares leap by 50-100% in less than a week i
Q BioMed, alert set for break above down-trend Q BioMed, Inc. operates as a biomedical acceleration and development company. It focuses on acquiring, licensing, and providing resources to life sciences and healthcare companies. Its products include Strontium 89, QBM-001, Uttroside-B, and MAN 01. The company was founded by Enrique Navas on Novemb
Buy Signal in Q BIOMEDQ BioMed, Inc. operates as a biomedical acceleration and development company. It focuses on acquiring, licensing, and providing resources to life sciences and healthcare companies. Its products include Strontium 89, QBM-001, Uttroside-B, and MAN 01. The company was founded by Enrique Navas on Novemb
$QBIO is on a Wild Ride with Buy-the-Dip SignalsQBIO
Q BioMed Inc. (OTCMKTS:QBIO) is another roller coaster in play on the OTC. This is an interesting player in the small float small-cap biotech growth space that has projects in motion to attack a major growth market (non-verbal learning disorder) with little competition and big potential. And
Q BIOMED INC,MAY AT LAST HAVE FOUND A BOTTOM, REVERSAL TRADE.Technically the chart of OTC:QMED is starting to look more bullish since the start of July, possibly a base is formed and a bottoming complete. Significant resistance will hamper the recovery, but if considering a long maybe a break of the downtrend in price and RSI would be a buy signal.
AVERAG
$QBIO back on high alert; shows +68pct Upside Potential!=====================
QBIO (Q BioMed Inc.)
Alert Price: $2.00
Float: 9.2M
Chart Analysis
Investor Presentation
Fact Sheet
Shareholder Update
Corporate Update Video
========================
Members,
It was an ugly day on Wall St. to say the least.
The Dow Jones Industrial Average
$QBIO is our New Low-float, BioTech Alert w/ MASSIVE UPSIDE!=====================
QBIO (Q BioMed Inc.)
Alert Price: $1.77
Float: 9.2M
Investor Presentation
Fact Sheet
Shareholder Update
Corporate Update Video
========================
Members,
We hope you enjoyed the over +23% in realistic profit that Wednesday's alert provided.
Earlier to
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of QBIO is 0.0002 USD — it has increased by 100.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Q BioMed Inc. stocks are traded under the ticker QBIO.
Q BioMed Inc. is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
QBIO stock is 50.00% volatile and has beta coefficient of −196.79. Check out the list of the most volatile stocks — is Q BioMed Inc. there?
QBIO earnings for the last quarter are −0.16 USD per share, whereas the estimation was −0.08 USD resulting in a −100.00% surprise. The estimated earnings for the next quarter are −0.10 USD per share. See more details about Q BioMed Inc. earnings.
Q BioMed Inc. revenue for the last quarter amounts to 20.00 K USD despite the estimated figure of 20.00 K USD. In the next quarter revenue is expected to reach 1.00 M USD.
Yes, you can track Q BioMed Inc. financials in yearly and quarterly reports right on TradingView.
QBIO stock has risen by 100.00% compared to the previous week, the month change is a 100.00% rise, over the last year Q BioMed Inc. has showed a 98.68% decrease.
No, QBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, QBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Q BioMed Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 7.00 employees. See our rating of the largest employees — is Q BioMed Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Q BioMed Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Q BioMed Inc. stock shows the sell signal. See more of Q BioMed Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.